Yes, movement symptoms can and do appear in Alzheimer’s disease, though many people don’t realize this is part of the condition. While memory loss defines Alzheimer’s in the public mind, the disease gradually damages brain regions that control motor function, balance, and coordination. A person diagnosed with Alzheimer’s might begin shuffling when they walk, experience stiffness in their limbs, or struggle with fine motor tasks like buttoning a shirt—changes that happen alongside or sometimes before severe cognitive decline becomes obvious.
These movement problems emerge because Alzheimer’s pathology (the buildup of amyloid plaques and tau tangles) spreads throughout the brain, not just the hippocampus and memory centers. The motor cortex, cerebellum, and basal ganglia—structures that coordinate movement—are vulnerable to this damage. A 78-year-old man diagnosed with early-stage Alzheimer’s might notice his handwriting has become shaky and smaller, or his wife observes that he no longer swings his arms when he walks. These aren’t separate neurological conditions; they’re part of how Alzheimer’s unfolds over time.
Table of Contents
- How Movement Changes Develop Across Alzheimer’s Stages
- The Brain Basis for Movement Decline in Alzheimer’s Disease
- Early Movement Changes You Might Notice
- Separating Alzheimer’s Movement Symptoms from Other Conditions
- Keeping People with Alzheimer’s Safe as Movement Declines
- How Alzheimer’s Medications and Disease Progression Interact with Movement
- When to Seek Specialized Evaluation for Movement Concerns
How Movement Changes Develop Across Alzheimer’s Stages
Movement symptoms typically worsen as Alzheimer’s progresses, though the timeline varies significantly between individuals. In the early stage, changes might be subtle—a slight slowness when getting out of a chair, mild balance issues, or reduced coordination during activities like cooking. By the middle stage, gait disturbances become more pronounced; a person may develop a shuffling walk, take shorter steps, or need to hold onto furniture for stability. In the late stage, movement becomes severely impaired, and many people lose the ability to walk independently or control basic motor functions. The reason movement deteriorates has to do with how the disease spreads through connected neural networks. Alzheimer’s damages the white matter tracts that carry signals from the motor cortex down the spinal cord and out to muscles.
This creates a disconnect between the brain’s intention to move and the body’s ability to execute that movement smoothly. A middle-stage patient might want to stand up from a chair but find their legs slow to respond, or their body stiff and resistant. This is not laziness or weakness in the traditional sense; it’s a breakdown in neural communication. Some people experience parkinsonian features—tremors, rigidity, and bradykinesia (slowness of movement)—that mimic Parkinson’s disease. Others develop ataxia, a loss of coordination and balance that makes walking unsteady. The specific pattern depends on which brain regions are most affected by Alzheimer’s pathology in that individual, which is why movement symptoms vary widely from person to person.
The Brain Basis for Movement Decline in Alzheimer’s Disease
Understanding where movement symptoms come from requires looking at the brain structures involved. The basal ganglia, a set of interconnected nuclei deep in the brain, regulate motor planning and smooth, automatic movement. The cerebellum coordinates balance and fine motor control. The supplementary motor area helps plan complex sequences of movement. All of these regions accumulate Alzheimer’s pathology and suffer neuronal loss as the disease advances. A key limitation in recognizing Alzheimer’s movement symptoms is that they often get overlooked or attributed to aging, arthritis, or unrelated neurological conditions.
A person might be told they have “normal age-related slowness” when the underlying cause is actually Alzheimer’s-related brain damage. This misattribution can delay diagnosis and prevent families from accessing appropriate support and monitoring. Clinicians should ask about gait changes, balance problems, and loss of coordination when evaluating someone with cognitive concerns, because these motor signs can be early markers of Alzheimer’s. The progression is not always linear. Some patients plateau at a certain level of motor decline, while others deteriorate rapidly. Environmental factors, comorbid conditions (like arthritis or stroke), medications, and the person’s baseline fitness all influence how visible and disabling the movement problems become. A person with Alzheimer’s who is physically active and well-conditioned might mask mild movement symptoms longer than someone who is sedentary.
Early Movement Changes You Might Notice
Early movement changes are often the first physical signs a family member detects, even before memory complaints become prominent. Loss of fine motor control is common; handwriting becomes smaller and shakier, a phenomenon called micrographia. A person might struggle to tie shoelaces, button shirts, or cut food with a knife. They may spill drinks more frequently or drop objects because finger dexterity is diminishing. Gait changes are another early marker. You might notice your parent or spouse walks more slowly than before, takes shorter steps, or shuffles slightly.
They may have trouble with turns and need to slow down or use a wall for support when changing direction. Some people develop a stooped posture, leaning forward more than they used to. These changes often happen gradually enough that family members attribute them to “just getting older,” missing the significance that they’re neurological decline tied to Alzheimer’s pathology. Balance problems and increased fall risk emerge early and escalate significantly as the disease progresses. A person might become unsteady on stairs, hesitant when walking on uneven surfaces, or more prone to stumbling. They may grab onto railings or ask for an arm to hold during walks. This increased fall risk is a serious concern because falls in older adults with Alzheimer’s can lead to fractures, head injuries, and a sudden drop in functional ability.
Separating Alzheimer’s Movement Symptoms from Other Conditions
Distinguishing Alzheimer’s-related movement problems from other neurological or orthopedic conditions is crucial but challenging. Parkinson’s disease also causes slowness, stiffness, and tremor, yet the underlying brain pathology is different (Lewy bodies rather than amyloid and tau). Some people have both conditions—a situation called Lewy body dementia or Parkinson’s disease dementia—which complicates the clinical picture. A neurologist examining someone with slowness and stiffness needs to assess whether the pattern fits primary Parkinson’s (where movement symptoms typically appear first) or Alzheimer’s with parkinsonian features (where cognitive decline precedes or accompanies the movement problems). Stroke can cause sudden, one-sided movement weakness that looks different from Alzheimer’s gradual, bilateral decline.
Cervical spine problems like stenosis can cause gait disturbance and hand clumsiness. Normal pressure hydrocephalus presents with a triad of gait disturbance, urinary incontinence, and cognitive decline, mimicking Alzheimer’s but requiring different treatment. The tradeoff is that detailed neurological examination and sometimes imaging are needed to sort out the contributions of each condition. A person might have mild cervical arthritis, early Alzheimer’s, and a previous small stroke, all contributing to their movement symptoms simultaneously. Brain imaging and cerebrospinal fluid biomarkers can help confirm Alzheimer’s pathology, but movement symptoms alone are not specific enough to diagnose any single condition. This is why comprehensive evaluation by a neurologist or geriatrician experienced with dementia is important—they can integrate the movement findings with cognitive testing, neuroimaging, and other clinical details.
Keeping People with Alzheimer’s Safe as Movement Declines
As movement symptoms progress, the risk of falls, injuries, and loss of independence increases dramatically. Home safety modifications become essential: removing throw rugs, installing grab bars in bathrooms, ensuring adequate lighting, clearing clutter from hallways, and securing furniture so it won’t tip if grabbed for balance. A person with mild gait instability might benefit from a cane or walker, though the decision to introduce mobility aids should be individualized; some people adapt well, while others resist or become frustrated. A critical warning: medications used to treat other aspects of Alzheimer’s or comorbid psychiatric symptoms can worsen movement problems. Antipsychotics, which are sometimes used to manage agitation or behavioral changes in Alzheimer’s, can increase stiffness, slowness, and fall risk—and should be used cautiously and at the lowest effective dose.
Similarly, medications for other conditions (anticholinergics for urinary incontinence, some blood pressure medications) can impair balance and coordination. Caregivers and clinicians need to review all medications regularly and consider whether any are contributing to movement decline. Physical therapy and structured exercise programs can help maintain mobility and strength as long as the person is able to participate. Walking, seated exercises, balance training, and strength work may slow the rate of functional decline, though they cannot stop the underlying Alzheimer’s process. The limitation is that as cognitive decline worsens, the person may lose the ability to follow instructions or remember what they practiced, reducing the benefit of therapy. Group exercise programs or one-on-one sessions with a therapist familiar with dementia can help adapt approaches to the person’s current abilities.
How Alzheimer’s Medications and Disease Progression Interact with Movement
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) and memantine are the main disease-modifying or symptom-reducing medications used in Alzheimer’s. These drugs work on neurotransmitter systems and can sometimes have motor-related side effects. Rivastigmine, for example, can cause or worsen nausea, which might make a person move less or become more sedentary—indirectly worsening motor decline.
Conversely, some patients report that these medications, particularly in early Alzheimer’s, provide modest cognitive benefit that helps them maintain engagement in activities and exercise longer. Newer monoclonal antibodies targeting amyloid (aducanumab, lecanemab) represent a different approach and may slow cognitive decline in early stages, but long-term effects on movement symptoms are still being studied. The hope is that slowing brain pathology early in the disease might delay the onset of motor complications, but definitive evidence on movement outcomes is limited. An important practical point: any medication change should be monitored closely for effects on balance, gait, and fall risk, particularly in older adults taking multiple drugs.
When to Seek Specialized Evaluation for Movement Concerns
If movement symptoms appear to be worsening rapidly, appear asymmetrically (one side much more affected than the other), or include tremors or rigidity that are particularly pronounced, a neurology evaluation is warranted. These features might suggest a concurrent condition like stroke, Parkinson’s disease, or progressive supranuclear palsy that requires different management. A person who was stable in their gait but suddenly becomes unable to walk should prompt urgent assessment; this could indicate a fall with injury, medication change, infection, or acute neurological event.
Occupational therapy evaluation is valuable for assessing fine motor function, hand strength, and coordination, and for recommending adaptive equipment or strategies to maintain independence in self-care tasks. A speech-language pathologist can evaluate swallowing safety, as Alzheimer’s-related movement changes can also affect the muscles used in swallowing, increasing aspiration risk. Coordinated input from multiple disciplines gives caregivers a realistic picture of current abilities and a practical plan for maintaining safety and quality of life as the disease progresses.
- —
